These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31623293)

  • 1. Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks.
    Sun M; Zhou W; Qi X; Zhang G; Girnita L; Seregard S; Grossniklaus HE; Yao Z; Zhou X; Stålhammar G
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.
    Zhang H; Kalirai H; Acha-Sagredo A; Yang X; Zheng Y; Coupland SE
    Transl Vis Sci Technol; 2020 Sep; 9(2):50. PubMed ID: 32953248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of molecular subclasses of uveal melanoma by deep learning using routine haematoxylin-eosin-stained tissue slides.
    Akram F; de Bruyn DP; van den Bosch QCC; Trandafir TE; van den Bosch TPP; Verdijk RM; de Klein A; Kiliç E; Stubbs AP; Brosens E; von der Thüsen JH
    Histopathology; 2024 Jul; ():. PubMed ID: 38952117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
    Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
    Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain.
    Tabuenca Del Barrio L; Nova-Camacho LM; Zubicoa Enériz A; Martínez de Espronceda Ezquerro I; Córdoba Iturriagagoitia A; Borque Rodríguez-Maimón E; García-Layana A
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma.
    See TR; Stålhammar G; Phillips S; Grossniklaus HE
    Ocul Oncol Pathol; 2020 Mar; 6(2):129-137. PubMed ID: 32258021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of HSP-27, BAP1, BRAF V600E, CCR7, and PD-L1 expression in uveal melanoma on enucleated eyes and metastatic liver tumors.
    Ağın A; Kiratli H; Guresci S; Babaoglu B; Karakaya J; Soylemezoglu F
    Int J Biol Markers; 2022 Jun; 37(2):200-209. PubMed ID: 35341390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the timing of BAP1 mutation in uveal melanoma progression.
    Uner OE; See TRO; Szalai E; Grossniklaus HE; Stålhammar G
    Sci Rep; 2021 Apr; 11(1):8923. PubMed ID: 33903674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
    van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
    Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Gene Expression Profile Prediction for Uveal Melanoma from Digital Cytopathology Images via Deep Learning and Salient Image Region Identification.
    Liu TYA; Chen H; Gomez C; Correa ZM; Unberath M
    Ophthalmol Sci; 2023 Mar; 3(1):100240. PubMed ID: 36561353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.
    Baqai U; Purwin TJ; Bechtel N; Chua V; Han A; Hartsough EJ; Kuznetsoff JN; Harbour JW; Aplin AE
    Mol Cancer Res; 2022 Aug; 20(8):1260-1271. PubMed ID: 35426938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma.
    Donizy P; Krzyzinski M; Markiewicz A; Karpinski P; Kotowski K; Kowalik A; Orlowska-Heitzman J; Romanowska-Dixon B; Biecek P; Hoang MP
    Eur J Cancer; 2022 Oct; 174():251-260. PubMed ID: 36067618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
    Carbone M; Ferris LK; Baumann F; Napolitano A; Lum CA; Flores EG; Gaudino G; Powers A; Bryant-Greenwood P; Krausz T; Hyjek E; Tate R; Friedberg J; Weigel T; Pass HI; Yang H
    J Transl Med; 2012 Aug; 10():179. PubMed ID: 22935333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
    Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW
    JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.